Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.
2.

Cocaethylene, a metabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels.

Xu YQ, Crumb WJ Jr, Clarkson CW.

J Pharmacol Exp Ther. 1994 Oct;271(1):319-25.

PMID:
7965731
3.

Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.

Ponce-Balbuena D, López-Izquierdo A, Ferrer T, Rodríguez-Menchaca AA, Aréchiga-Figueroa IA, Sánchez-Chapula JA.

J Pharmacol Exp Ther. 2009 Nov;331(2):563-73. doi: 10.1124/jpet.109.156075.

4.
5.

Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action.

Kushida S, Ogura T, Komuro I, Nakaya H.

Eur J Pharmacol. 2002 Dec 13;457(1):19-27.

PMID:
12460639
6.

Voltage-dependent gating and block by internal spermine of the murine inwardly rectifying K+ channel, Kir2.1.

Matsuda H, Oishi K, Omori K.

J Physiol. 2003 Apr 15;548(Pt 2):361-71. Erratum in: J Physiol. 2003 Jun 15;549(Pt 3):995.

7.
8.

Theoretical possibilities for the development of novel antiarrhythmic drugs.

Varró A, Biliczki P, Iost N, Virág L, Hála O, Kovács P, Mátyus P, Papp JG.

Curr Med Chem. 2004 Jan;11(1):1-11. Review.

PMID:
14754422
9.
10.

Na+ permeation and block of hERG potassium channels.

Gang H, Zhang S.

J Gen Physiol. 2006 Jul;128(1):55-71.

11.

Open channel block of Kv3.1 currents by fluoxetine.

Sung MJ, Ahn HS, Hahn SJ, Choi BH.

J Pharmacol Sci. 2008 Jan;106(1):38-45.

12.

Electrophysiologic characterization of a novel hERG channel activator.

Su Z, Limberis J, Souers A, Kym P, Mikhail A, Houseman K, Diaz G, Liu X, Martin RL, Cox BF, Gintant GA.

Biochem Pharmacol. 2009 Apr 15;77(8):1383-90. doi: 10.1016/j.bcp.2009.01.015.

PMID:
19426677
13.

Inhibition of cloned HERG potassium channels by the antiestrogen tamoxifen.

Thomas D, Gut B, Karsai S, Wimmer AB, Wu K, Wendt-Nordahl G, Zhang W, Kathöfer S, Schoels W, Katus HA, Kiehn J, Karle CA.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Jul;368(1):41-8.

PMID:
12827215
14.

Effects of protein kinase C on delayed rectifier K+ channel regulation by tyrosine kinase in rat retinal pigment epithelial cells.

Strauss O, Rosenthal R, Dey D, Beninde J, Wollmann G, Thieme H, Wiederholt M.

Invest Ophthalmol Vis Sci. 2002 May;43(5):1645-54.

PMID:
11980886
15.

Potent inhibition of human cardiac potassium (HERG) channels by the anti-estrogen agent clomiphene-without QT interval prolongation.

Yuill KH, Borg JJ, Ridley JM, Milnes JT, Witchel HJ, Paul AA, Kozlowski RZ, Hancox JC.

Biochem Biophys Res Commun. 2004 May 28;318(2):556-61.

PMID:
15120636
16.
17.

Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes.

Bosch RF, Schneck AC, Csillag S, Eigenberger B, Gerlach U, Brendel J, Lang HJ, Mewis C, Gögelein H, Seipel L, Kühlkamp V.

Naunyn Schmiedebergs Arch Pharmacol. 2003 Mar;367(3):281-8.

PMID:
12644901
18.

Atypical tetracyclic antidepressant maprotiline is an antagonist at cardiac hERG potassium channels.

Kiesecker C, Alter M, Kathöfer S, Zitron E, Scholz EP, Thomas D, Kreuzer J, Katus HA, Bauer A, Karle CA.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Jun;373(3):212-20.

PMID:
16736158
19.

An ion channel 'addicted' to ether, alcohol and cocaine: the HERG potassium channel.

Karle CA, Kiehn J.

Cardiovasc Res. 2002 Jan;53(1):6-8. Review. No abstract available.

20.

Zn(2+) slows down Ca(V)3.3 gating kinetics: implications for thalamocortical activity.

Cataldi M, Lariccia V, Marzaioli V, Cavaccini A, Curia G, Viggiano D, Canzoniero LM, di Renzo G, Avoli M, Annunziato L.

J Neurophysiol. 2007 Oct;98(4):2274-84.

Items per page

Supplemental Content

Support Center